Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$110.72 - $210.04 $11,072 - $21,004
-100 Closed
0 $0
Q4 2020

Jan 11, 2021

BUY
$79.67 - $173.23 $7,967 - $17,323
100 New
100 $15,000
Q1 2020

Apr 20, 2020

SELL
$33.68 - $62.53 $1,616 - $3,001
-48 Closed
0 $0
Q4 2019

Jan 27, 2020

BUY
$36.68 - $73.13 $1,760 - $3,510
48 New
48 $2,000
Q3 2019

Oct 09, 2019

SELL
$40.99 - $52.56 $1,967 - $2,522
-48 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$35.45 - $48.2 $1,701 - $2,313
48 New
48 $2,000
Q4 2018

Jan 14, 2019

SELL
$22.73 - $42.34 $62,462 - $116,350
-2,748 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$44.35 - $65.71 $121,873 - $180,571
2,748 New
2,748 $0

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track True Private Wealth Advisors Portfolio

Follow True Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.